Integrative methylation profiling uncovers IL10RB hypomethylation as a mediator between environmental heavy metal exposure and lung cancer risk.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
294 participants.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Our findings indicate that long-term exposure to heavy metals in environmentally vulnerable areas alters methylation patterns, potentially affecting disease risk.
Residents living in areas exposed to environmental hazards, such as abandoned mines and refineries, are hypothesized to exhibit distinct omics profiles compared with those in unaffected regions.
APA
Shin H, Kim CH, et al. (2026). Integrative methylation profiling uncovers IL10RB hypomethylation as a mediator between environmental heavy metal exposure and lung cancer risk.. Environmental pollution (Barking, Essex : 1987), 390, 127537. https://doi.org/10.1016/j.envpol.2025.127537
MLA
Shin H, et al.. "Integrative methylation profiling uncovers IL10RB hypomethylation as a mediator between environmental heavy metal exposure and lung cancer risk.." Environmental pollution (Barking, Essex : 1987), vol. 390, 2026, pp. 127537.
PMID
41397497 ↗
Abstract 한글 요약
Residents living in areas exposed to environmental hazards, such as abandoned mines and refineries, are hypothesized to exhibit distinct omics profiles compared with those in unaffected regions. In this article, we aimed to identify the differentially methylated regions (DMRs) affected by these hazards using Forensic Research via Omics Markers in Environmental Health Vulnerable Areas (FROM) cohort. We then evaluated the potential effects of these DMRs on 23 human diseases by using data from the Korean Genome and Epidemiology Study (KoGES) cohort, which included 79,294 participants. We conducted a DMR analysis using reduced representation bisulfite sequencing on peripheral blood mononuclear cells samples, and employed the Meet-in-the-Middle analysis to identify biomarkers that enable more precise and biologically meaningful interpretation with the forensic research via FROM cohort, and significant findings were further validated with one-sample Mendelian Randomization (MR) method. To explore relationships between these biomarkers and 23 diseases, the two-sample MR approach within the KoGES cohort was conducted. Our findings indicate that long-term exposure to heavy metals in environmentally vulnerable areas alters methylation patterns, potentially affecting disease risk. Notably, a DMR in the IL10RB gene region was identified, where hypomethylation was associated with the development of lung cancer (P = 1.92 × 10, β = -1.7830). This study highlights the potential epigenetic impact of environmental exposures and underscores the importance of uncovering biomarkers linking exposure to disease outcome.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Correspondence to the Editorial "Aspirin on the prevention of hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease".
- Multicenter Assessment of Postoperative Mastocheck Dynamics Following Curative Breast Cancer Surgery.
- Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial.
- Surgical Site Infection Caused by Mycobacterium Septicum Following Blepharoplasty.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.